338 related articles for article (PubMed ID: 25153169)
1. Evaluation of prognostic integrin α2β1 PET tracer and concurrent targeting delivery using focused ultrasound for brain glioma detection.
Chung YH; Hsu PH; Huang CW; Hsieh WC; Huang FT; Chang WC; Chiu H; Hsu ST; Yen TC
Mol Pharm; 2014 Nov; 11(11):3904-14. PubMed ID: 25153169
[TBL] [Abstract][Full Text] [Related]
2. The Use of PET Imaging for Prognostic Integrin α
Huang CW; Hsieh WC; Hsu ST; Lin YW; Chung YH; Chang WC; Chiu H; Lin YH; Wu CP; Yen TC; Huang FT
Theranostics; 2017; 7(16):4013-4028. PubMed ID: 29109795
[TBL] [Abstract][Full Text] [Related]
3. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of
Liu Q; Cai S; Ye J; Xie Q; Liu R; Qiu L; Lin J
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1826-1840. PubMed ID: 38319321
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
[TBL] [Abstract][Full Text] [Related]
6. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.
Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W
Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906
[TBL] [Abstract][Full Text] [Related]
8. Improved positron emission tomography imaging of glioblastoma cancer using novel
Loft MD; Sun Y; Liu C; Christensen C; Huang D; Kjaer A; Cheng Z
Amino Acids; 2017 Jun; 49(6):1089-1100. PubMed ID: 28316028
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.
Persson M; Nedergaard MK; Brandt-Larsen M; Skovgaard D; Jørgensen JT; Michaelsen SR; Madsen J; Lassen U; Poulsen HS; Kjaer A
J Nucl Med; 2016 Feb; 57(2):272-8. PubMed ID: 26429955
[TBL] [Abstract][Full Text] [Related]
10. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts.
Shen Y; Pi Z; Yan F; Yeh CK; Zeng X; Diao X; Hu Y; Chen S; Chen X; Zheng H
Int J Nanomedicine; 2017; 12():5613-5629. PubMed ID: 28848341
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
[TBL] [Abstract][Full Text] [Related]
12. Complementary, Selective PET Imaging of Integrin Subtypes α5β1 and αvβ3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin.
Notni J; Steiger K; Hoffmann F; Reich D; Kapp TG; Rechenmacher F; Neubauer S; Kessler H; Wester HJ
J Nucl Med; 2016 Mar; 57(3):460-6. PubMed ID: 26635338
[TBL] [Abstract][Full Text] [Related]
13. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
[TBL] [Abstract][Full Text] [Related]
14. Targeting VPAC1 Receptors for Imaging Glioblastoma.
Tripathi SK; Kean R; Bongiorno E; Hooper DC; Jin YY; Wickstrom E; McCue PA; Thakur ML
Mol Imaging Biol; 2020 Apr; 22(2):293-302. PubMed ID: 31292914
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies.
Kiviniemi A; Gardberg M; Autio A; Li XG; Heuser VD; Liljenbäck H; Käkelä M; Sipilä H; Kurkipuro J; Ylä-Herttuala S; Knuuti J; Minn H; Roivainen A
Acta Oncol; 2014 Aug; 53(8):1125-34. PubMed ID: 24957558
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and validation of integrin α2β1-targeted probe for microPET imaging of prostate cancer.
Huang CW; Li Z; Cai H; Chen K; Shahinian T; Conti PS
Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1313-22. PubMed ID: 21350963
[TBL] [Abstract][Full Text] [Related]
17. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
Haubner R; Wester HJ; Burkhart F; Senekowitsch-Schmidtke R; Weber W; Goodman SL; Kessler H; Schwaiger M
J Nucl Med; 2001 Feb; 42(2):326-36. PubMed ID: 11216533
[TBL] [Abstract][Full Text] [Related]
18. Quantitative kinetics of [124I]FIAU in cat and man.
Jacobs A; Bräunlich I; Graf R; Lercher M; Sakaki T; Voges J; Hesselmann V; Brandau W; Wienhard K; Heiss WD
J Nucl Med; 2001 Mar; 42(3):467-75. PubMed ID: 11337525
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Boron Uptake in Brain Glioma by a Boron-Polymer/Microbubble Complex with Focused Ultrasound.
Fan CH; Wang TW; Hsieh YK; Wang CF; Gao Z; Kim A; Nagasaki Y; Yeh CK
ACS Appl Mater Interfaces; 2019 Mar; 11(12):11144-11156. PubMed ID: 30883079
[TBL] [Abstract][Full Text] [Related]
20. (68)Ga-PRGD2 PET/CT in the evaluation of Glioma: a prospective study.
Li D; Zhao X; Zhang L; Li F; Ji N; Gao Z; Wang J; Kang P; Liu Z; Shi J; Chen X; Zhu Z
Mol Pharm; 2014 Nov; 11(11):3923-9. PubMed ID: 25093246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
